Pathogenesis and management of vascular calcification in CKD and dialysis patients
Authors:
- 29 August 2019
- journal article
- review article
- Published by Wiley in Seminars in Dialysis
- Vol. 32 (6) , 553-561
Abstract
Patients with chronic kidney disease (CKD) have a predisposition to develop vascular calcification due to dysregulated homeostatic mechanisms, which lead to an imbalance in the circulatory promoters and inhibitors of vascular calcification, leading to a net calcification stress. These factors promote ectopic calcification and induce vascular smooth muscle cells to undergo osteogenic differentiation and actively calcify the vascular media. The article summarizes clinically relevant pathogenic mechanisms of vascular calcification in patients with CKD and in dialysis patients and summarizes novel therapeutic interventions. In addition to the management of traditional cardiovascular risk factors, patients with CKD‐mineral and bone disorder need close attention in the management of the mineral metabolism to prevent adverse effects on the bone and vascular compartments. This article reviews current evidence and therapeutic guidelines in the management of mineral metabolism in CKD and dialysis.Keywords
This publication has 95 references indexed in Scilit:
- Effect of Cinacalcet on Cardiovascular Disease in Patients Undergoing DialysisNew England Journal of Medicine, 2012
- Calcium balance in normal individuals and in patients with chronic kidney disease on low- and high-calcium dietsKidney International, 2012
- Vitamin D Therapy and Cardiac Structure and Function in Patients With Chronic Kidney DiseaseJAMA, 2012
- A case-control study of calciphylaxis in Japanese end-stage renal disease patientsNephrology Dialysis Transplantation, 2011
- Progression of coronary artery calcification and cardiac events in patients with chronic renal disease not receiving dialysisKidney International, 2011
- The link between bone and coronary calcifications in CKD-5 patients on haemodialysisNephrology Dialysis Transplantation, 2010
- Serum iPTH, calcium and phosphate, and the risk of mortality in a European haemodialysis populationNephrology Dialysis Transplantation, 2010
- A Comparison of Sevelamer and Calcium-Based Phosphate Binders on Mortality, Hospitalization, and Morbidity in Hemodialysis: A Secondary Analysis of the Dialysis Clinical Outcomes Revisited (DCOR) Randomized Trial Using Claims DataAmerican Journal of Kidney Diseases, 2008
- Effects of sevelamer and calcium-based phosphate binders on mortality in hemodialysis patientsKidney International, 2007
- Mortality effect of coronary calcification and phosphate binder choice in incident hemodialysis patientsKidney International, 2007